Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F14%3A33150049" target="_blank" >RIV/61989592:15310/14:33150049 - isvavai.cz</a>

Result on the web

<a href="http://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20141001&DB=EPODOC&locale=en_EP&CC=EP&NR=2391626B1&KC=B1&ND=4" target="_blank" >http://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20141001&DB=EPODOC&locale=en_EP&CC=EP&NR=2391626B1&KC=B1&ND=4</a>

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds

Original language description

The invention relates to newly prepared substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds.

Czech name

—

Czech description

—

Type

P - Patent

CEP classification

FR - Pharmacology and apothecary chemistry

OECD FORD branch

—

Project

<a href="/en/project/LO1204" target="_blank" >LO1204: Sustainable development of research in the Centre of the Region Haná</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>S - Specificky vyzkum na vysokych skolach

Publication year

2014

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Patent/design ID

EP2391626

Publisher

EPO_1 -

Publisher name

European Patent Office

Place of publication

Munich, The Hague, Berlin, Vienna, Brussels

Publication country

—

Date of acceptance

Oct 1, 2014

Owner name

Univerzita Palackého v Olomouci, BioApex, s.r.o.

Method of use

B - Výsledek je využíván orgány státní nebo veřejné správy

Usage type

A - K využití výsledku jiným subjektem je vždy nutné nabytí licence